BRAF v600e
Title:BRAF v600e
URL:http://www.clarientinc.com
Category:Health: Hospitals and Medical Centers
Description:The BRAF (V600E) mutation analysis is predictive for anti-EGFR therapies (i.e., cetuximab and panitumumab). BRAF mutations account for approximately 12-15% of colorectal cancer patients.
ID:13952